How cellular plasticity drives cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainAbout 90% of deaths from cancer are a result of metastasis—that is, from cancer's ability to spread from

Updated on: April 28,2024

How cellular plasticity drives cancer metastasis

by Ian Demsky,Memorial Sloan Kettering Cancer CenterCredit: Unsplash/CC0 Public DomainAbout 90% of deaths from cancer are a result of metastasis—that is, from cancer's ability to spread from

Updated on:April 28,2024

Russia's Cancer Vaccine 'Enteromix': A Breakthrough Using mRNA Technology

Updated on: September 15,2025

Russia's Cancer Vaccine 'Enteromix': A Breakthrough Using mRNA Technology

Updated on:September 15,2025

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on: December 18,2023

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on:December 18,2023

Predicting prostate cancer recurrence 15 months sooner

by Steve Martin,Purdue UniversityGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.105430A Purdue University mechanical engineer and his international collaborators

Updated on: January 06,2024

Predicting prostate cancer recurrence 15 months sooner

by Steve Martin,Purdue UniversityGraphical abstract. Credit:iScience(2022). DOI: 10.1016/j.isci.2022.105430A Purdue University mechanical engineer and his international collaborators

Updated on:January 06,2024

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on: December 22,2023

Molecular tumor boards improve outcomes for patients with advanced cancer

by Elizabeth Chapin,University of KentuckyWaterfall plot detailing individual PFS ratio (PFS2/PFS1) values for patients treated with second-line or greater-line MTB-directed therapy (cohort 1; n

Updated on:December 22,2023

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in

Updated on: December 20,2023

Phase I clinical trial of the first drug to successfully inhibit the MYC gene that drives many common cancers

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainResearchers report that a drug targeting the cancer-causing gene MYC inhibits the function of the gene in

Updated on:December 20,2023

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Updated on: January 04,2024

Chemotherapy before surgery can improve survival rates in pancreatic cancer patients

byUniversity of LiverpoolCredit: CC0 Public DomainTreating pancreatic cancer patients with chemotherapy before surgery significantly improved 1-year survival rates compared to immediate surgery,

Updated on:January 04,2024

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

Updated on: March 21,2024

New research finds oral leukemia therapy to work as well as intravenous decitabine

by Hackensack Meridian HealthCredit: Pixabay/CC0 Public DomainResearchers at Hackensack Meridian's John Theurer Cancer Center (JTCC), are part of a published Phase 3 study reporting on the equival

Updated on:March 21,2024

Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

by Tara Copp And Shirsho Dasgupta, Mcclatchy Washington BureauCredit: CC0 Public DomainThe Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilot

Updated on: April 18,2024

Are fighter pilots at greater risk for prostate cancer? The Air Force is now asking

by Tara Copp And Shirsho Dasgupta, Mcclatchy Washington BureauCredit: CC0 Public DomainThe Air Force has begun to look at whether there's increased risk for prostate cancer among its fighter pilot

Updated on:April 18,2024

Robotic resection cuts perioperative morbidity with liver cancer

by Lori SolomonRobotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), ac

Updated on: December 25,2023

Robotic resection cuts perioperative morbidity with liver cancer

by Lori SolomonRobotic liver resection (RLR) is associated with a significant reduction in perioperative morbidity for treatment of hepatocellular carcinoma (HCC) versus open-liver resection (OLR), ac

Updated on:December 25,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on: December 26,2023

Integrating mental health services into oncology treatment protocols

byThe City University of New YorkStudy participant is interviewed. Credit: The City University of New YorkA new study by CUNY SPH doctoral student Thinh Vu and colleagues reveals that cancer inp

Updated on:December 26,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on: December 22,2023

Study offers a potential strategy to improve T cell therapy in solid tumors

byPerelman School of Medicine at the University of PennsylvaniaRegnase-1 and Roquin-1 double knockout alters the activation profile of resting engineered T cells. (A) Healthy human donor T cells

Updated on:December 22,2023